Publications
The Burden of Non-Communicable Diseases in India E-mail

[October 19, 2010]  As of 2005, India experienced the “highest loss in potentially productive years of life” worldwide, according to an article published in The Lancet.The projected cumulative loss of national income for India due to non-communicable disease mortality for 2006-2015 will be USD237 billion. By 2030, this productivity loss was expected to double to 17.9 million years lost – almost 1,000% greater than the corresponding loss in the United States, which has a population a third the size of India’s.

Read more...
 
Pharmaceutical Access in Least Developed Countries: on-the-ground barriers and industry successes E-mail

[Sept. 28, 2010] Today, The Cameron Institute released a report highlighting the importance of public-private partnerships and of intellectual property protections to improving global health. The evidence in this report strongly supports North-South, public-private partnerships as the preferred means by which to improve access to care and public health outcomes in least-developed countries.

Read more...
 
We know with accuracy only when we know little E-mail

Stuart MacLeod
Executive Director, Child & Family Research Institute; Vice President, Provincial Health Services Authority; Associate Dean (Research), University of British Columbia

Craig Mitton
Senior Scientist, Centre for Clinical Epidemiology and Evaluation;
Associate Professor, School of Population and Public Health, University of British Columbia

Our title reflects a maxim penned by Goethe. It continues in translation to read ‘With knowledge doubt increases.’1 The papers that appear in this issue stemming from a special symposium held in Banff, Alberta in February 2009, describe our progress toward agreement on the concept of access with evidence development (AED).2-6
Read more...
 
Summary Report - Benefit-Risk Roundtable E-mail

On Friday, March 5, 2010, over thirty Canadian health stakeholders (representing patients, providers, government, academics and industry) participated in a roundtable meeting to discuss the new paradigm of benefit-risk introduced in Bill C-51.

Read more...
 
Canadian Roundtable on Clinical Considerations for Subsequent Entry Biologics E-mail

Key learning points for physicians, pharmacists and patients.

Read more...
 
<< Start < Prev 1 2 3 4 5 Next > End >>

Page 3 of 5